Literature DB >> 32909828

Cannabis Use and Prospective Long-Term Association with Anxiety: A Systematic Review and Meta-Analysis of Longitudinal Studies: Usage du cannabis et association prospective à long terme avec l'anxiété: une revue systématique et une méta-analyse d'études longitudinales.

Siqi Xue1, M Ishrat Husain1,2, Haoyu Zhao2, Arun V Ravindran1,2.   

Abstract

OBJECTIVES: Cannabis use is proposed as a risk factor for psychosis and is associated with depressive disorders. However, the relationship between recreational cannabis use and its longitudinal implications on anxiety conditions is less studied. The aim of this investigation is to systematically evaluate published literature and perform a meta-analysis of the data.
METHODS: A systematic search was performed of MEDLINE, Embase, and PsychINFO from inception to May 31, 2020, in addition to a hand search. Longitudinal studies that evaluated the relationship of cannabis use and development of anxiety were included. Where applicable, adjusted odds ratios (ORs) were extracted, pooled, and evaluated using random-effects meta-analysis.
RESULTS: After screening of unique abstracts (n = 6835), the final evaluation included 24 studies, of which 10 reported ORs that were analyzed quantitatively. Cannabis use was significantly associated with increased odds of developing any anxiety conditions (OR = 1.25; 95% CI, 1.01 to 1.54). Cannabis use was not significantly associated with developing generalized anxiety disorder, panic disorder, or social anxiety disorder. Review of studies not reporting OR revealed mixed results but are suggestive of a link between cannabis use and increased rates/severity of anxiety.
CONCLUSIONS: Published evidence suggests that cannabis use is likely associated with increased risk of anxiety in the long term but variability of study designs precludes declaration of a causal relationship. Awareness of this association is of relevance for both clinical practice and mental health policy implementation.

Entities:  

Keywords:  anxiety; cannabis use disorders; cohort study; meta-analysis; systematic reviews

Year:  2020        PMID: 32909828      PMCID: PMC7918873          DOI: 10.1177/0706743720952251

Source DB:  PubMed          Journal:  Can J Psychiatry        ISSN: 0706-7437            Impact factor:   4.356


  58 in total

1.  Quantifying heterogeneity in a meta-analysis.

Authors:  Julian P T Higgins; Simon G Thompson
Journal:  Stat Med       Date:  2002-06-15       Impact factor: 2.373

2.  Trajectories of marijuana use from adolescence to young adulthood: predictors and outcomes.

Authors:  Michael Windle; Margit Wiesner
Journal:  Dev Psychopathol       Date:  2004

3.  The short-term consequences of early onset cannabis use.

Authors:  D M Fergusson; M T Lynskey; L J Horwood
Journal:  J Abnorm Child Psychol       Date:  1996-08

4.  Has Marijuana Legalization Increased Marijuana Use Among US Youth?

Authors:  Wayne Hall; Megan Weier
Journal:  JAMA Pediatr       Date:  2017-02-01       Impact factor: 16.193

5.  Reductions in cannabis use are associated with improvements in anxiety, depression, and sleep quality, but not quality of life.

Authors:  Yih-Ing Hser; Larissa J Mooney; David Huang; Yuhui Zhu; Rachel L Tomko; Erin McClure; Chih-Ping Chou; Kevin M Gray
Journal:  J Subst Abuse Treat       Date:  2017-07-29

6.  Meta-analysis in clinical trials.

Authors:  R DerSimonian; N Laird
Journal:  Control Clin Trials       Date:  1986-09

Review 7.  Adolescent exposure to cannabis as a risk factor for psychiatric disorders.

Authors:  Tiziana Rubino; Erica Zamberletti; Daniela Parolaro
Journal:  J Psychopharmacol       Date:  2011-07-18       Impact factor: 4.153

Review 8.  Cannabis and anxiety: a critical review of the evidence.

Authors:  José Alexandre Crippa; Antonio Waldo Zuardi; Rocio Martín-Santos; Sagnik Bhattacharyya; Zerrin Atakan; Philip McGuire; Paolo Fusar-Poli
Journal:  Hum Psychopharmacol       Date:  2009-10       Impact factor: 1.672

Review 9.  Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review.

Authors:  Theresa H M Moore; Stanley Zammit; Anne Lingford-Hughes; Thomas R E Barnes; Peter B Jones; Margaret Burke; Glyn Lewis
Journal:  Lancet       Date:  2007-07-28       Impact factor: 79.321

Review 10.  Cannabidiol as a Potential Treatment for Anxiety Disorders.

Authors:  Esther M Blessing; Maria M Steenkamp; Jorge Manzanares; Charles R Marmar
Journal:  Neurotherapeutics       Date:  2015-10       Impact factor: 7.620

View more
  4 in total

1.  Cannabis containing equivalent concentrations of delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) induces less state anxiety than THC-dominant cannabis.

Authors:  Nadia R P W Hutten; T R Arkell; F Vinckenbosch; J Schepers; R C Kevin; E L Theunissen; K P C Kuypers; I S McGregor; J G Ramaekers
Journal:  Psychopharmacology (Berl)       Date:  2022-10-13       Impact factor: 4.415

2.  Cannabis use among youth in Canada: a scoping review protocol.

Authors:  Toula Kourgiantakis; Travonne Edwards; Eunjung Lee; Judith Logan; Ragave Vicknarajah; Shelley L Craig; Monique Simon-Tucker; Charmaine C Williams
Journal:  BMJ Open       Date:  2022-06-20       Impact factor: 3.006

3.  Associations between self-reported cannabis use frequency, potency, and cannabis/health metrics.

Authors:  Christine M Steeger; Leah N Hitchcock; Angela D Bryan; Kent E Hutchison; Karl G Hill; L Cinnamon Bidwell
Journal:  Int J Drug Policy       Date:  2021-05-30

Review 4.  Impact of Acute and Chronic Cannabis Use on Stress Response Regulation: Challenging the Belief That Cannabis Is an Effective Method for Coping.

Authors:  Mustafa al'Absi; Alicia M Allen
Journal:  Front Psychol       Date:  2021-07-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.